LAUREN FORD: Open Payments
NPI 1235605163 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 26 payments from 16 companies in 2025. Trend: 2023 $778 · 2024 $328 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Dexcom, Inc. | 2 | $65 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Lilly USA, LLC | 3 | $49 |
| ABBVIE INC. | 2 | $36 |
| SHIELD THERAPEUTICS INC | 2 | $33 |
| Astellas Pharma US Inc | 2 | $32 |
| Sage Therapeutics, LLC | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $21 |
Products named: MYFEMBREE, Dexcom G6 Transmitter, INJECTAFER, ZEPBOUND, LO LOESTRIN FE, ACCRUFER, Veozah, ZURZUVAE.
Industry payments across LA — which companies pay providers there.
